Indian Adalimumab Exporters: Complete Supplier Ranking with Market Share — 97 Manufacturers (2026) — TransData Nexus

Q: Who is the largest adalimumab buyer importing from India?

D. K. M. PHARMACEUTICALS PVT. LTD. (NEPAL) is the largest adalimumab importer from India with a 4.2% market share and import value of $49.8K.

Q: How many adalimumab buyers import from India?

There are 97 active adalimumab buyers importing from India, with a combined import market of $1.2M across 223 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top adalimumab buyers from India?

The top 5 adalimumab buyers — D. K. M. PHARMACEUTICALS PVT. LTD., D K M PHARMACEUTICALS PRIVATE LIMITED, UNITED STATES PHARMACOPEIAL CONVEN, PHARMACHEM PRIVATE LIMITED, D K M PHARMACEUTICALS PVT LTD — together control 12.9% of total adalimumab import value from India.

Suresh Sormare

Adalimumab

India Pharmaceutical Trade Intelligence

$1.2M67 Suppliers53 CountriesHS 30021500

ExportsIndia → VENEZUELA27.9%India → SRI LANKA20.0%

ImportsUNITED STATES → India$167.7K UNITED KINGDOM → India$28.5K

#1 Supplier: RELIANCE LIFE

Market Analysis: Top Importing Countries & Their Importers

1Venezuela

Venezuela emerges as the first largest importing country, achieving a total trade value of $332.6K through 0 shipments. This represents a market share of 27.9% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Venezuela demonstrates strong market positioning with an average shipment value of $332.6K, indicating premium pricing strategy compared to the market average of $5.3K.

Venezuela is a key market for Adalimumab imports, representing 27.9% of total trade value.

Primary Market

Secondary Market

2Sri Lanka

Sri Lanka emerges as the second largest importing country, achieving a total trade value of $238.3K through 0 shipments. This represents a market share of 20.0% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: Sri Lanka demonstrates strong market positioning with an average shipment value of $238.3K, indicating premium pricing strategy compared to the market average of $5.3K.

Sri Lanka is a key market for Adalimumab imports, representing 20.0% of total trade value.

Buyer Segment Analysis

TransData Nexus Adalimumab buyer market intelligence

1Buyer Segment Analysis

The importers of Adalimumab from India can be categorized into several segments:

1. Distributors: Entities like D. K. M. Pharmaceuticals Pvt. Ltd. in Nepal, which appears multiple times in the top buyer list, function as intermediaries, purchasing Adalimumab in bulk and supplying it to various healthcare providers. Their buying behavior typically involves large, periodic orders to maintain a steady supply chain.

2. Government Procurement Agencies: Organizations such as the United States Pharmacopeial Convention (USA) are involved in setting quality standards and may procure Adalimumab for research or public health initiatives. Their procurement is often characterized by adherence to strict regulatory standards and scheduled tenders.

3. Re-exporters: Companies like Radeep Services in Singapore may import Adalimumab with the intent to re-export to other markets, leveraging Singapore's strategic position as a global trade hub. Their purchasing patterns are influenced by international demand and trade agreements.

4. Hospital Groups and Retail Chains: While not explicitly listed among the top buyers, these entities typically procure Adalimumab directly for patient treatment, focusing on consistent supply to meet patient needs.

5. Contract Manufacturers: These are companies that might import Adalimumab as an active pharmaceutical ingredient (API) for formulation into finished products. Their procurement is usually aligned with production schedules and contractual obligations.

The repeat buyer rate of 48.5% indicates a significant level of recurring demand, suggesting that many importers have established ongoing relationships with Indian exporters to ensure a consistent supply of Adalimumab.

Country-Specific Import Regulations

TransData Nexus Adalimumab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Adalimumab are as follows:

1. Venezuela:

Drug Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

Import Registration Process: Requires submission of a dossier including product information, manufacturing details, and clinical data.

Estimated Timeline for Registration: Approximately 12 to 18 months.

Import Tariff/Duty for HS 30021500: Specific tariff rates are subject to change; importers should consult the latest customs tariff schedule.

2. Sri Lanka:

Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

Import Registration Process: Submission of an application with product details, GMP certificates, and samples.

Demand Drivers & Market Opportunity

TransData Nexus Adalimumab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Adalimumab in importing countries is driven by several factors:

1. Disease Prevalence: Adalimumab is primarily used to treat autoimmune conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease. The prevalence of these conditions in countries like Venezuela, Sri Lanka, Nepal, Bangladesh, and the UAE contributes to the consistent demand for this biologic therapy.

2. Government Healthcare Programs: Many of these countries have initiated programs to improve access to essential medicines. For instance, the inclusion of Adalimumab in national formularies and treatment guidelines facilitates its procurement and distribution.

3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in these regions have led to increased access to biologic therapies, including Adalimumab, as part of comprehensive healthcare services.

4. WHO Essential Medicines List Procurement: While Adalimumab is not currently listed on the WHO Essential Medicines List, its recognition in national essential medicines lists can influence procurement decisions, especially in countries aligning their policies with WHO recommendations.

5. Tender-Based Purchasing: Public sector procurement in these countries often involves competitive tendering processes, which can lead to significant price reductions and increased accessibility of Adalimumab.

The presence of 97 buyers across 53 countries indicates a broad and diverse market for Adalimumab imported from India, reflecting its global demand and the opportunities for Indian exporters to expand their reach.

TransData Nexus Research · Government and regulatory sources

Common Questions — Adalimumab Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest adalimumab buyer importing from India?

Based on import volume and value, D. K. M. PHARMACEUTICALS PVT. LTD. (NEPAL) leads with $49.8K in imports and a 4.2% market share — the highest of any single adalimumab importer. D K M PHARMACEUTICALS PRIVATE LIMITED (NEPAL) and UNITED STATES PHARMACOPEIAL CONVEN (UNITED STATES) are the next largest buyers.

QHow many companies buy adalimumab from India?

There are 97 active adalimumab buyers importing from India, with a combined market of $1.2M across 223 shipments to 53 countries. The top 5 buyers hold 12.9% of total import value, while the remaining 92 buyers handle the other 87.1%.

QWhich countries import the most adalimumab from India?

The top importing countries for adalimumab from India are Venezuela (27.9%), Sri Lanka (20.0%), Nepal (10.9%), Bangladesh (9.9%), United Arab Emirates (6.6%). These markets represent the largest demand centres for Indian pharmaceutical exports of adalimumab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for adalimumab from India?

The average import transaction value for adalimumab from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Adalimumab buyer market intelligence

1Buyer Segment Analysis

The importers of Adalimumab from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Adalimumab buyer market intelligence

1Country-Specific Import Regulations

For the top five importing countries, the import regulations for Adalimumab are as follows:

1. Venezuela:

Drug Regulatory Authority: Instituto Nacional de Higiene Rafael Rangel (INHRR).

Import Registration Process: Requires submission of a dossier including product information, manufacturing details, and clinical data.

Estimated Timeline for Registration: Approximately 12 to 18 months.

Import Tariff/Duty for HS 30021500: Specific tariff rates are subject to change; importers should consult the latest customs tariff schedule.

2. Sri Lanka:

Drug Regulatory Authority: National Medicines Regulatory Authority (NMRA).

Import Registration Process: Submission of an application with product details, GMP certificates, and samples.

Demand Drivers & Market Opportunity

TransData Nexus Adalimumab buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Adalimumab in importing countries is driven by several factors:

TransData Nexus Research · Government and regulatory sources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Adalimumab

Adalimumab

Who Buys Adalimumab from India — 97 Importers Behind a $1.2M Market

Top Adalimumab Importers — Ranked by Import Value

Top Adalimumab Buyers & Importers

Related Analysis

Need Details?

Adalimumab — Export Intelligence Video

Market Analysis: Top Importing Countries & Importers

Which companies are buying Adalimumab — and from which countries?

Adalimumab — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Venezuela

2Sri Lanka

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Adalimumab Buyers & Importers

QWho is the largest adalimumab buyer importing from India?

QHow many companies buy adalimumab from India?

QWhich countries import the most adalimumab from India?

QWhat is the average import order value for adalimumab from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Nepal

4Bangladesh

5United Arab Emirates

Analysis Methodology